TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2008

Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.

Michael P DiGiovanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.